FURIEX PHARMACEUTICALS INC's ticker is FURX and the CUSIP is 36106P101. A total of 86 filers reported holding FURIEX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $4,969,000 | +9.0% | 46,800 | -10.7% | 0.00% | 0.0% |
| Q1 2014 | $4,557,000 | +140.5% | 52,386 | +16.1% | 0.00% | +200.0% |
| Q4 2013 | $1,895,000 | -3.5% | 45,117 | +1.1% | 0.00% | -50.0% |
| Q3 2013 | $1,964,000 | +31.6% | 44,646 | +2.0% | 0.00% | +100.0% |
| Q2 2013 | $1,492,000 | – | 43,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 349,356 | $15,368,000 | 10.66% |
| Consonance Capital Management LP | 761,764 | $33,510,000 | 8.38% |
| Global Alpha Capital Management Ltd. | 66,974 | $3,028,000 | 4.92% |
| Breithorn Capital Management | 59,158 | $2,602,000 | 1.52% |
| Artal Group S.A. | 971,051 | $42,717,000 | 1.39% |
| Montibus Capital Management LLC | 190,286 | $8,370,681,000 | 0.90% |
| THOMPSON SIEGEL & WALMSLEY LLC | 551,606 | $24,265,000 | 0.53% |
| FRANKLIN STREET ADVISORS INC /NC | 43,950 | $1,933,000 | 0.43% |
| AMERICAN CAPITAL MANAGEMENT INC | 49,392 | $2,173,000 | 0.29% |
| Spark Investment Management LLC | 28,200 | $1,240,000 | 0.28% |